SWOT Analysis for Vivos Therapeutics Inc - Weakness

Add SWOT widget to your site/app

Relative Outperformance versus Industry over 1 Week

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Results Screener: Stocks with upcoming results which are seeing positive shifts in share price

Relative Outperformance versus Industry over 1 Month

Companies with Low Debt

Companies with reducing Debt

Increasing Revenue every quarter for the past 2 quarters

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Stock with Low PE (PE < = 10)

RSI indicating price strength

Volume Shockers

Stocks with Quarter Change % less than Industry

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Highest fall from 52 Week High

Top Losers

Low Piotroski Score : Companies with weak financials

Recent Results: Declining Operating Profit Margin and Net Profits (YoY)

Declining profits every quarter for the past 4 quarters

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Companies with Upcoming Results

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months